2020
DOI: 10.1038/s41388-020-1176-9
|View full text |Cite
|
Sign up to set email alerts
|

AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
71
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 68 publications
(73 citation statements)
references
References 44 publications
2
71
0
Order By: Relevance
“…The morphology of mitochondrial is dynamically regulated by the balance between fusion and ssion events to maintain energy and metabolic homeostasis [12] . During recent years, a series of studies have revealed the close links between the unbalanced mitochondrial dynamics and various human cancers [15] , including liver [16,17] , breast [18,19] , lung [20,21] and colon [22] cancers. MIEF2 (mitochondrial elongation factor 2) is a outer mitochondrial membrane protein involved in the regulation of mitochondrial ssion [23] .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The morphology of mitochondrial is dynamically regulated by the balance between fusion and ssion events to maintain energy and metabolic homeostasis [12] . During recent years, a series of studies have revealed the close links between the unbalanced mitochondrial dynamics and various human cancers [15] , including liver [16,17] , breast [18,19] , lung [20,21] and colon [22] cancers. MIEF2 (mitochondrial elongation factor 2) is a outer mitochondrial membrane protein involved in the regulation of mitochondrial ssion [23] .…”
Section: Discussionmentioning
confidence: 99%
“…During the lifetime of a cell, the morphology and function of mitochondrial is continuously remodeled by the balance between ssion and fusion events [12][13][14] . During recent years, the close links between fragmented mitochondrial networks and cancer has been revealed in various types of human cancers [15] , including liver [16,17] , breast [18,19] , lung [20,21] and colon [22] cancers. In addition, abnormal expressions of mitochondria ssion and fusion proteins such as DRP1 (dynamin related protein 1) and MFN1 (mitofusion 1) have also been observed.…”
Section: Introductionmentioning
confidence: 99%
“…AIM2 is a dsDNA sensor that is mainly activated in monocytes and macrophages by cytoplasmic DNA, derived from pathogens or neighboring necrotic cells (Briard et al, 2020). In addition, there is accumulating evidence for AIM2 to be involved in sustaining mitochondrial function by detecting mitochondrial DNA (mtDNA) in various human diseases, including cancer and diabetes type 2 (Bae et al, 2019;Qi et al, 2020), as well as in detecting virus-induced oxidized DNA (Moriyama et al, 2020). In neurodevelopment, AIM2 was recently shown to be involved in surveillance of DNA damage of neurons (Lammert et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…148 Furthermore, it has been recently reported that AIM2 expression positively correlates with the growth and proliferation of NSCLC cells in vitro and in vivo and that AIM2 expression in NSCLC tumors is associated with poor prognosis in patient. 91 AIM2 promotion of cell proliferation was independent of its inflammasome function; AIM2 has been found to colocalize with mitochondria in NSCLC cells and modulate mitochondrial fission and fusion dynamics to facilitate growth and proliferation of cancer cells.…”
Section: Infl Amma Some-independent Fun C Ti On S Of Aim2mentioning
confidence: 94%
“…High expression of AIM2 is observed in non-small cell lung cancer (NSCLC), and AIM2 plays both inflammasome-dependent and inflammasome-independent roles in NSCLC. [90][91][92] In an in vitro study with lung cancer epithelial cell lines A549 and H460, the depletion of AIM2 and ASC with shRNA and siRNA, respectively, as well as inhibition of caspase-1 with VX765, inhibited cell growth and metastasis. Furthermore, the depletion of AIM2 and ASC and the inhibition of caspase-1 promoted cell-cycle arrest at G2/M phase, which paralleled with cyclin B1 reduction in these cell lines.…”
Section: Cancermentioning
confidence: 99%